Objectives-To see whether autonomic regulatory mechanisms play a part in transient myocardial ischaemia in patients treated with ,B blockers. Design-Prospective study. Setting-Outpatients' clinic. Patients-51 consecutive patients with angiographically documented coronary artery disease, stable angina, and transient myocardial ischaemia despite /1 blockade. Interventions-24 hour ambulatory electrocardiographic monitoring for analysis of variability in ST depression and heart rate. Main outcome measures-Numbers of episodes of ischaemia, with an ST depression of > 0-1 mV 80 ms after the J point that lasted > 60 s at an interval of > 60 s from a previous ischaemic episode. Heart rate at onset of ischaemia. Normalised spectral analysis of heart rate variability; ratio of low to high frequency power to assess the sympathovagal balance. Results-Despite treatment, 258 episodes of transient ischaemia were recorded. At heart rates at onset of ischaemia of < 70 beats per minute a high ratio of low to high frequency power accompanied the ischaemic events and was paralleled by a remarkably reduced high frequency power. The high ratio-that is, enhanced sympathetic tone during ischaemia-was mainly found in the early morning. By contrast, ischaemic episodes with heart rates at onset of > 70 beats per minute were not associated with significant changes in the parameters of autonomic function.
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Conclusions-During / blockade the residual transient ischaemia is associated with decreased variability in heart rate. In particular, in ischaemic episodes with a low heart rate at onset the neural regulation of the heart plays a part. Apparently, variability in heart rate is not sufficiently modified by / blockers to prevent all ischaemia. The ischaemia related change in the autonomic nervous system during the early morning is in agreement with previous studies, showing increased cardiovascular risk at this time of the day. (Br HeartrJ 1995; 73:134-138) Keywords: autonomic nervous system; daytime transient myocardial ischaemia; coronary artery disease Studies in animals and humans have shown that the autonomic nervous system is important for maintaining coronary vascular tone.' In coronary artery disease a change in the functioning of the autonomic nervous system may therefore play a part in precipitating myocardial ischaemic events. The circadian variation of these events is typified by a higher incidence in the early morning, which may be related to an increase in coronary tone. At this time of the day other factors such as increased platelet aggregability, increase in concentrations of vasoactive hormones, and decreased fibrinolytic activity also may play a part. [2] [3] [4] [5] Obviously, /3 blockade may change the neural regulation underlying these circadian phenomena. 6 Apart from a beneficial effect of ,B blockers on transient myocardial ischaemia, recent reports suggest that these drugs facilitate ischaemia at low heart rates. 7 The neural regulation of the heart can be studied by measuring heart rate variability in a 24 hour Holter recording.8 The spontaneous beat to beat changes in the electrocardiographic RR intervals are studied with spectral analysis. Vagal efferent activity has been interpreted as being primarily responsible for the high frequency component of the spectrum. 9 The low frequency component is considered to be related to both vagal and sympathetic outflow.'0 Vagal and sympathetic activity may act reciprocally, but also in a non-reciprocal way." The ratio of low to high frequency power of this spectral analysis has been reported to reflect a balance between both autonomic influences, which has been validated by tilt testing and controlled respiration. 12 Holter monitoring might help to elucidate autonomic mechanisms underlying transient myocardial ischaemia.
We investigated the relation between the circadian variation in ftunctioning of the autonomic nervous system and the occurrence of transient myocardial ischaemia in patients with stable coronary artery disease who had been treated with /3 blockers.
Patients and methods
Ambulatory electrocardiographic monitoring was performed in consecutive patients from the outpatients' clinic who were taking a cardioselective /3 blocker for stable angina pectoris. All had significant coronary artery disease, which was defined as a reduction in vessel diameter of at least 50% on coronary angiography. Patients with left ventricular dysfunction (left ventricular ejection fraction < 30%) were excluded. Episodes were classified as ischaemic when an ST segment depression of > 0 1 mV lasting for > 60 s occurred 80 ms after the J point and was separated by > 60 s from a previous ischaemic episode. The time of occurrence and heart rate at the onset of ischaemia were nloted for each episode. The median heart rate at the onset of ischaemia served as the cut off point to create two groups of ischaemic episodes in order to estimate whether impaired supply or increased demand of nutrients was the cause of myocardial ischaemia. Ventricular tachycardia was defined as a run of three or more ventricular ectopic beats with a rate of > 100 beats per minute.
After RR intervals containing ectopic beats were discounted, spectral analysis of heart rate variability was performed using the Marquette 001A program (Marquette Laser System, Milwaukee, Wisconsin, USA). This software computes heart rate variability using RR intervals of consecutive two minute segments and produces average values for each hour as well as a mean of 24 hour values. In this program total frequency was defined as the spectral power between 0.01 Hz and 1I00
Hz, low frequency as that between 0 04 Hz and 0 15 Hz, and high frequency (HF) as that between 0 15 Hz and 0 40 Hz. We used power units in Ms,'2 after which normalised units for this frequency power was obtained by dividing high frequency by total frequency and low frequency by total frequency. Unreliable spectral curves in periods of distortion were not included in the study. The ratio of sympathovagal balance was defined as the low frequency power divided by high frequency power. To assess the relation between heart rate variability and transient ischaemia spectral analysis of heart rate variability was performed in the hour in which the ischaemic episode occurred and in the hour afterwards. The circadian variation of heart rate variability in relation to the occurrence of ischaemia was assessed by plotting hourly values of the ratio of low to high frequency.
STATISTICAL ANALYSIS
Heart rate variability parameters during ischaemia were considered to be independent variables. Average heart rate variabilities for the separate episodes are presented in relation to 24 hour means per patient. Owing to the unequal distribution of ischaemic episodes among the patients, no attempt was made to analyse the data on a per patient basis. A nonpaired t test was used to compare the normally distributed heart rate variability parameters during ischaemic events with a heart rate onset of below and above the median. Circadian variation in the hourly values for heart rate variability was tested by repeated measures analysis of variance. Data are presented as means (SE). Differences were considered significant when a P value of less than 0 05 was observed. Despite treatment, 258 episodes of transient ischaemia were noted, which were all asymptomatic. The median number of ischaemic episodes per patient was 3 (range 1-28). The incidence of ischaemia rose in the early morning, and ischaemia was completely absent between 0100 and 0400.
HEART RATE VARIABILITY Spectral analyses are depicted in figures 1 and 2. During ischaemia total power and high frequency power were reduced compared with 24 hour means. A subsequent rise in all components of spectral power was seen after ischaemia (figure 1). After normalisationthat is, through correction of changes in total power-the high frequency power appeared low during ischaemia and thereafter. The ratio of low to high frequency power as well as Heart rate at Heart rate onset <70 beats/min _70 beats/min normalised low frequency power increased during ischaemia (figure 2). Median heart rate at the onset of ischaemia was 70 beats per minute. In 109 episodes a heart rate at onset of < 70 beats per minute was present, and 149 episodes had a heart rate at onset of > 70 beats per minute. The high ratio of low to high frequency power in these patients taking blockers was predominantly found in episodes with a heart rate at onset of ischaemia below 70 beats per minute. In episodes with an onset heart rate > 70 beats per minute there were no significant changes in the spectral components of heart rate variability or their ratio (figure 3). The duration of ischaemia and the total ischaemic burden showed no consistent relation to heart rate variability parameters.
CIRCADIAN PATrERN OF HOURLY HEART RATE

VARIABILITY
The day to night variation in the mean hourly ratio of low to high frequency power is illustrated in figure 4 . In the absence of ischaemia, the curve was flat, showing no (fig 1) . After correction for changes in total power, normalised high frequency spectral power was lower on average during ischaemic episodes (figure 2). When heart rate at the onset of ischaemia was taken into consideration, alterations in neural control were most prominent during episodes with an onset frequency below 70 beats per minute. In other words, these episodes seem to be related to parasympathetic withdrawal with subsequent reciprocal augmentation of sympathetic activity."' Alternatively, neural mechanisms do not seem to play an important part in ischaemia associated with higher heart rates at onset.
To our knowledge this is the first study to show decreased normalised high frequency power as a cause for the increase in the ratio of low to high frequency found during ischaemia. It occurred in most episodes and, as mentioned above, mainly represents vagal inhibition. Morikami et al also proposed parasympathetic withdrawal as a mechanism of ischaemia. They performed handgrip testing in patients with variant angina and found a lower vagal activity a few minutes before coronary vasospasm was observed.'3 By contrast, Bernardi et al found an increase in low frequency power in asymptomatic nocturnal ischaemia.'4 They did not, however, consider low frequency power and the changes in total power during the day, which precludes a general conclusion about the nature of the change in sympathovagal balance. Our study unifies the contentions of the previous studies, as it The circadian rhythm in the ratio of low to high frequency power seen in patients who are not being treated was absent in our patients owing to ,B blockade.6 During ischaemia, however, there was a large variation in this ratio (figure 4). We found high values in the early morning, which is in agreement with the increase in sympathetic activity in the early morning reported by Furlan et al. ' 9 Using a non-spectral method, Malik et al also found that reduced heart rate variability was most prominent at 0600.20 In patients refractory to the anti-ischaemic effects of fi blockade the sympathovagal balance in the early morning seems to follow a pattern similar to that seen in control patients.6 0 0 0200 0400 0600 0800 1000 1200 1400 1600 1800 2000 2200 lime Figure 4 Hourly pattern in ratio oflow to high frequency power. In absence of ischaemia there is no day to night variation owing to fi blockade. During ischaemia there is a large variation in ratio, possibly because ofdifferences in heart rate at onset of ischaemia and physical activity. Note, however, the high early morning ratio, reflecting predominant sympathetic activity. (Not significant by repeated measures analysis of variance.)
shows the permissive role of vagal tone in the adrenergic activation leading to ischaemia. Above all, it underscores and supports previous work on the importance of considering sympathovagal balance rather than sympathetic or parasympathetic activation as both systems work reciprocally as well as in a nonreciprocal way.'2 MECHANISMS FOR ISCHAEMIA AT LOW HEART RATE Holter monitoring has shown that ischaemia can occur at low heart rates. Our results suggest that this type of ischaemia is facilitated by specific neural mechanisms. Obviously, low heart rate ischaemia is not associated with an increased oxygen demand.'5 Therefore, other mechanisms should be involved. From our study, neural regulation of the vascular tone and subsequent coronary narrowing could be held responsible for this type of ischaemia.
The extent to which fi blockers can enhance transient ischaemia at low heart rates cannot be estimated in our study. However, an increase in incidence of episodes of ischaemia at low heart rates after f, blockade was found by McLenachan et al.7 In addition, El-Tamimi et al describe an enhanced coronary vasoreactive response to acetylcholine in patients taking fi blockers.'6 Despite f, blockade, a high ratio of low to high frequency power was obtained during ischaemia at low heart rates, which shows sympathetic activity. This finding might imply a cardiac spillover of catecholamines, which can provoke paradoxical narrowing of diseased coronary segments. '7 18 Our data on the neural regulation of low heart rate ischaemia are compatible with the concept of vasomotor disturbance, in whichf blockers obviously have an important role.
NORMALISATION OF SPECTRAL ANALYSIS
Owing to a large variation in total spectral power, the spectral heart rate variability parameters might change considerably during the day, interfering with a unified interpretation of the results. Using an instantaneous heart rate function for spectral analysis, Arai et al reported an 18- 
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